Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53


Mitophagy: In sickness and in health.

Palikaras K, Lionaki E, Tavernarakis N.

Mol Cell Oncol. 2015 Jun 10;3(1):e1056332. doi: 10.1080/23723556.2015.1056332. eCollection 2016 Jan. Review.


From Ancient Pathways to Aging Cells-Connecting Metabolism and Cellular Senescence.

Wiley CD, Campisi J.

Cell Metab. 2016 Jun 14;23(6):1013-21. doi: 10.1016/j.cmet.2016.05.010. Review.


Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis.

Auburger G, Gispert S, Brehm N.

Parkinsons Dis. 2016;2016:4686185. doi: 10.1155/2016/4686185. Epub 2016 Mar 1.


Parkin Regulates the Activity of Pyruvate Kinase M2.

Liu K, Li F, Han H, Chen Y, Mao Z, Luo J, Zhao Y, Zheng B, Gu W, Zhao W.

J Biol Chem. 2016 May 6;291(19):10307-17. doi: 10.1074/jbc.M115.703066. Epub 2016 Mar 14.


Direct α-synuclein promoter transactivation by the tumor suppressor p53.

Duplan E, Giordano C, Checler F, Alves da Costa C.

Mol Neurodegener. 2016 Feb 2;11:13. doi: 10.1186/s13024-016-0079-2.


Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate.

Hess JA, Khasawneh MK.

BBA Clin. 2015 Feb 7;3:152-61. doi: 10.1016/j.bbacli.2015.01.006. eCollection 2015 Jun. Review.


Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.

Cha SH, Choi YR, Heo CH, Kang SJ, Joe EH, Jou I, Kim HM, Park SM.

Mol Neurodegener. 2015 Dec 1;10:63. doi: 10.1186/s13024-015-0060-5.


Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy.

Hamacher-Brady A, Brady NR.

Cell Mol Life Sci. 2016 Feb;73(4):775-95. doi: 10.1007/s00018-015-2087-8. Epub 2015 Nov 26. Review.


Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.

Ho DH, Kim H, Kim J, Sim H, Ahn H, Kim J, Seo H, Chung KC, Park BJ, Son I, Seol W.

Mol Brain. 2015 Sep 18;8:54. doi: 10.1186/s13041-015-0145-7.


The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.

Liu F, Zhang W, You X, Liu Y, Li Y, Wang Z, Wang Y, Zhang X, Ye L.

Oncotarget. 2015 Sep 29;6(29):27199-213. doi: 10.18632/oncotarget.4508.


Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.

Kollareddy M, Dimitrova E, Vallabhaneni KC, Chan A, Le T, Chauhan KM, Carrero ZI, Ramakrishnan G, Watabe K, Haupt Y, Haupt S, Pochampally R, Boss GR, Romero DG, Radu CG, Martinez LA.

Nat Commun. 2015 Jun 12;6:7389. doi: 10.1038/ncomms8389.


TAT-ODD-p53 enhances the radiosensitivity of hypoxic breast cancer cells by inhibiting Parkin-mediated mitophagy.

Zheng R, Yao Q, Xie G, Du S, Ren C, Wang Y, Yuan Y.

Oncotarget. 2015 Jul 10;6(19):17417-29.


Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment.

Justus CR, Sanderlin EJ, Yang LV.

Int J Mol Sci. 2015 May 15;16(5):11055-86. doi: 10.3390/ijms160511055. Review.


Inhibition of glucose-transporter 1 (GLUT-1) expression reversed Warburg effect in gastric cancer cell MKN45.

Zhang TB, Zhao Y, Tong ZX, Guan YF.

Int J Clin Exp Med. 2015 Feb 15;8(2):2423-8. eCollection 2015.


RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling.

Liu J, Zhang C, Wu R, Lin M, Liang Y, Liu J, Wang X, Yang B, Feng Z.

Oncotarget. 2015 Jun 20;6(17):14982-92.


Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.

Lin DC, Xu L, Chen Y, Yan H, Hazawa M, Doan N, Said JW, Ding LW, Liu LZ, Yang H, Yu S, Kahn M, Yin D, Koeffler HP.

Cancer Res. 2015 May 1;75(9):1815-27. doi: 10.1158/0008-5472.CAN-14-1433. Epub 2015 Apr 15.


Mitophagy and cancer.

Chourasia AH, Boland ML, Macleod KF.

Cancer Metab. 2015 Mar 26;3:4. doi: 10.1186/s40170-015-0130-8. eCollection 2015.


Cardiac deficiency of single cytochrome oxidase assembly factor scox induces p53-dependent apoptosis in a Drosophila cardiomyopathy model.

Martínez-Morentin L, Martínez L, Piloto S, Yang H, Schon EA, Garesse R, Bodmer R, Ocorr K, Cervera M, Arredondo JJ.

Hum Mol Genet. 2015 Jul 1;24(13):3608-22. doi: 10.1093/hmg/ddv106. Epub 2015 Mar 19.


Parkin structure and function.

Seirafi M, Kozlov G, Gehring K.

FEBS J. 2015 Jun;282(11):2076-88. doi: 10.1111/febs.13249. Epub 2015 Mar 16. Review.


Pathologic and therapeutic implications for the cell biology of parkin.

Charan RA, LaVoie MJ.

Mol Cell Neurosci. 2015 May;66(Pt A):62-71. doi: 10.1016/j.mcn.2015.02.008. Epub 2015 Feb 17. Review.

Items per page

Supplemental Content

Write to the Help Desk